Insider Trading Alert - ASFI, ICE And VICL Traded By Insiders

Yesterday, Jan. 8, 2016, 42 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $975.00 to $3,560,848.74.

Highlighted Stocks Traded by Insiders:

Asta Funding (ASFI) - FREE Research Report

Mangrove Partners Master Fund, Ltd., who is 10% Owner at Asta Funding, bought 17,933 shares at $7.73 on Jan. 8, 2016. Following this transaction, the 10% Owner owned 1.5 million shares meaning that the stake was boosted by 1.22% with the 17,933-share transaction.

The shares most recently traded at $7.99, up $0.26, or 3.31% since the insider transaction. Historical insider transactions for Asta Funding go as follows:

  • 4-Week # shares bought: 36,025
  • 12-Week # shares bought: 80,375
  • 12-Week # shares sold: 7,000
  • 24-Week # shares bought: 80,375
  • 24-Week # shares sold: 7,000

The average volume for Asta Funding has been 16,000 shares per day over the past 30 days. Asta Funding has a market cap of $93.3 million and is part of the services sector and diversified services industry. Shares are down 2.77% year-to-date as of the close of trading on Thursday.

Asta Funding, Inc., together with its subsidiaries, engages in consumer receivable business in the United States. The company operates through four segments: Consumer Receivables, Personal Injury Claims, Structured Settlements, and GAR Disability Advocacy. The company has a P/E ratio of 51.5. Currently, there are no analysts who rate Asta Funding a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ASFI - FREE

TheStreet Quant Ratings rates Asta Funding as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and increase in net income. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, disappointing return on equity and weak operating cash flow. Get the full Asta Funding Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

IntercontinentalExchange Group (ICE) - FREE Research Report

Mathison Dean S, who is Chief Accounting Officer at IntercontinentalExchange Group, sold 596 shares at $250.43 on Jan. 8, 2016. Following this transaction, the Chief Accounting Officer owned 2,249 shares meaning that the stake was reduced by 20.95% with the 596-share transaction.

The shares most recently traded at $210.28, down $40.15, or 19.09% since the insider transaction. Historical insider transactions for IntercontinentalExchange Group go as follows:

  • 4-Week # shares sold: 2,893
  • 12-Week # shares sold: 11,301
  • 24-Week # shares sold: 11,801

The average volume for IntercontinentalExchange Group has been 967,000 shares per day over the past 30 days. IntercontinentalExchange Group has a market cap of $24.7 billion and is part of the financial sector and financial services industry.

Intercontinental Exchange, Inc. operates a network of regulated exchanges and clearing houses for financial and commodity markets in the United States, the United Kingdom, Continental Europe, Israel, Canada, and Singapore.

Exclusive Offer: Get the latest Stock Analysis on ICE - FREE

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Vical (VICL) - FREE Research Report

Samant Vijay B, who is President & CEO at Vical, sold 75,000 shares at $0.36 on Jan. 8, 2016. Following this transaction, the President & CEO owned 1.1 million shares meaning that the stake was reduced by 6.57% with the 75,000-share transaction.

The shares most recently traded at $0.36, down $0.00, or 0.33% since the insider transaction. Historical insider transactions for Vical go as follows:

  • 4-Week # shares bought: 564,494
  • 4-Week # shares sold: 193
  • 12-Week # shares bought: 564,494
  • 12-Week # shares sold: 193
  • 24-Week # shares bought: 564,494
  • 24-Week # shares sold: 5,905

The average volume for Vical has been 432,600 shares per day over the past 30 days. Vical has a market cap of $32.8 million and is part of the health care sector and drugs industry. Shares are down 9.76% year-to-date as of the close of trading on Friday.

Vical Incorporated engages in the research and development of biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Currently, there is 1 analyst who rates Vical a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on VICL - FREE

TheStreet Quant Ratings rates Vical as a sell. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself. Get the full Vical Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

In Trump Era, Managing JPMorgan Is As Unpredictable As a Midnight Tweet

In Trump Era, Managing JPMorgan Is As Unpredictable As a Midnight Tweet

Video: Don't Underestimate China's Strength in a Trade War

Video: Don't Underestimate China's Strength in a Trade War

Master Limited Partnerships: A Badly Missed Investment Opportunity?

Master Limited Partnerships: A Badly Missed Investment Opportunity?

America's Massive Truck Driver Shortage May Triple by 2026: Experts

America's Massive Truck Driver Shortage May Triple by 2026: Experts

Top Analysts Say Gamble On These 3 Ace Stocks

Top Analysts Say Gamble On These 3 Ace Stocks